Overview

Gibtulio (Empagliflozin) is an oral medication used to improve glycemic control in adults with type 2 diabetes. It works by inhibiting the sodium-glucose co-transporter 2 (SGLT2), leading to increased glucose excretion in urine and reduced blood sugar levels.

Benefits

• Helps lower blood sugar levels effectively.
• May assist in weight loss for some patients.
• Reduces the risk of cardiovascular events in patients with established heart disease.
• Can be used in conjunction with other diabetes medications.

Dosage

The typical starting dose of Gibtulio is 10 mg once daily, which may be increased to 25 mg based on individual response and tolerability. It is recommended to take the medication in the morning, with or without food.

Side Effects

Common side effects of Gibtulio may include:

• Urinary tract infections
• Genital yeast infections
• Increased urination
• Dehydration

Serious side effects can include ketoacidosis and kidney problems. Consult your healthcare provider if you experience any severe symptoms.

FAQs

1. Who should not take Gibtulio?

Gibtulio is not recommended for individuals with severe kidney impairment or those on dialysis. Discuss your medical history with your healthcare provider before starting this medication.

2. Can I take Gibtulio with other diabetes medications?

Yes, Gibtulio can be used alongside other diabetes medications, but it is essential to consult your healthcare provider for proper management and monitoring.

3. What should I do if I miss a dose?

If you miss a dose of Gibtulio, take it as soon as you remember. If it's almost time for your next dose, skip the missed dose and resume your regular schedule. Do not double the dose.

4. Is Gibtulio safe during pregnancy?

The safety of Gibtulio during pregnancy has not been established. Consult your healthcare provider if you are pregnant, plan to become pregnant, or are breastfeeding.